The Fridley, Minn.-based company recently informed employees at the facilities that it planned to eliminate its Portsmouth jobs, according to the report. The facilities currently employ 150 individuals.
Medtronic spokesperson Brett Cromwell said that the transformative solutions division had announced changes “being made to help focus the business and strengthen its financial position,” according to the Portsmouth Herald.
“The business is being restructured and will report into Medtronic’s enabling technologies business in Louisville, Colorado, beginning April 27. As a result of the transition, the Portsmouth facility will eventually be closed, most likely within the next 12 months,” Cromwell said in a statement, according to the report.
Cromwell could not identify exactly which positions would be impacted, but indicated that many of the roles would be transitioned from Portsmouth to its Louisville, Colo.-based facilities.
“Portsmouth employees will have the opportunity to apply for those positions, as well as any other open positions at Medtronic. Any employees impacted by this transition will be offered a severance package and outplacement services,” Cromwell said, according to the Portsmouth Herald report.
Yesterday, Medtronic said that it launched its Deep Brain Stimulation system intended for medically-refractory epilepsy in the U.S.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.